Advertisement

Sex Differences in Epidemiology of Cardiac and Vascular Disease

  • Tatiana Kuznetsova
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1065)

Abstract

In spite of a remarkable decline in death rates from cardiovascular disease (CVD) observed over the last decades, CVD still remains the leading cause of mortality in both men and women worldwide. Overall the age-adjusted CVD mortality and morbidity rates are highest in men than in women. However, the risk of CVD in women should not be underestimated given that approximately one of two women in developed countries will die of mostly preventable heart diseases or stroke. Although men and women share the same cardiovascular risk factors, there are substantial sex differences in the first manifestation and clinical presentation of CVD. In this part of the chapter, we will discuss the recent epidemiological data on sex discrepancies in the prevalence and burden of different CVDs.

Keywords

Cardiovascular disease Coronary heart disease Stroke Peripheral arterial disease Mortality Morbidity Microcirculatory dysfunction Sex differences Misdiagnosis Risk profile 

References

  1. 1.
    Anderson RD, Pepine CJ. Gender differences in the treatment for acute myocardial infarction: bias or biology? Circulation. 2007;115:823–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40:1082–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Backholer K, Peters SAE, Bots SH, Peeters A, Huxley RR, Woodward M. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71:550–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46:287–95.CrossRefPubMedGoogle Scholar
  5. 5.
    Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health. 2017;2:e000298.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Boggia J, Thijs L, Hansen TW, Li Y, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Olszanecka A, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Maestre G, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA, International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes Investigators. Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension. 2011;57:397–405.CrossRefPubMedGoogle Scholar
  8. 8.
    Crea F, Battipaglia I, Andreotti F. Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis. 2015;241:157–68.CrossRefPubMedGoogle Scholar
  9. 9.
    Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005;112:1687–91.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.CrossRefGoogle Scholar
  11. 11.
    George J, Rapsomaniki E, Pujades-Rodriguez M, Shah AD, Denaxas S, Herrett E, Smeeth L, Timmis A, Hemingway H. How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circulation. 2015;132:1320–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Graciani A, León-Muñoz LM, Guallar-Castillón P, Rodríguez-Artalejo F, Banegas JR. Cardiovascular health in a Southern Mediterranean European country: a Nationwide population-based study. Circ Cardiovasc Qual Outcomes. 2013;6:90–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, Daviglus ML, Lloyd-Jones DM. Lifetime risk for heart failure among white and black Americans cardiovascular lifetime risk pooling project. J Am Coll Cardiol. 2013;61:1510–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Janković J, Marinković J, Stojisavljević D, Erić M, Vasiljević N, Janković S. Sex inequalities in cardiovascular health: a cross-sectional study. Eur J Pub Health. 2016;26:152–8.CrossRefGoogle Scholar
  15. 15.
    Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Chest. 1969;56:43–51.Google Scholar
  16. 16.
    Kardys I, Vliegenthart R, Oudkerk M, Hofman A, Witteman JC. The female advantage in cardiovascular disease: do vascular beds contribute equally? Am J Epidemiol. 2007;166:403–12.CrossRefPubMedGoogle Scholar
  17. 17.
    Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation. 2010;121:2317–25.CrossRefPubMedGoogle Scholar
  18. 18.
    Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, Heeringa J, Portegies ML, Hofman A, Ikram MA, Hunink MG, Franco OH, Stricker BH, Witteman JC, Roos-Hesselink JW. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–62.CrossRefPubMedGoogle Scholar
  20. 20.
    Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I, Vartiainen E, Sans S, Pasterkamp G, Hughes M, Costanzo S, Donati MB, Jousilahti P, Linneberg A, Palosaari T, de Gaetano G, Bobak M, den Ruijter HM, Mathiesen E, Jørgensen T, Söderberg S, Kuulasmaa K, Zeller T, Iacoviello L, Salomaa V, Schnabel RB, BiomarCaRE Consortium. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017;136:1588–97.CrossRefPubMedGoogle Scholar
  22. 22.
    Manteuffel M, Williams S, Chen W, et al. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt). 2014;23:112–9.CrossRefGoogle Scholar
  23. 23.
    Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33:1750–7.CrossRefGoogle Scholar
  24. 24.
    Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation. 2011;124:2145–54.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Nicholls SJ, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Tuzcu EM, Nissen SE. Rate of progression of coronary atherosclerotic plaque in women. J Am Coll Cardiol. 2007;49:1546–51.CrossRefPubMedGoogle Scholar
  26. 26.
    Niewada M, Kobayashi A, Sandercock PA, Kamiński B, Członkowska A, International Stroke Trial Collaborative Group. Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischemic stroke in the international stroke trial. Neuroepidemiology. 2005;24:123–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Olsen TS, Dehlendorff C, Andersen KK. Sex-related time-dependent variations in post-stroke survival: evidence of a female stroke survival advantage. Neuroepidemiology. 2007;29:218–25.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis. 2005;47:320–32.CrossRefPubMedGoogle Scholar
  29. 29.
    Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Authors/Task Force Members. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–81.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Reeves MJ, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915–26.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97:1–37.CrossRefPubMedGoogle Scholar
  33. 33.
    Remme WJ, McMurray JJ, Rauch B, Zannad F, Keukelaar K, Cohen-Solal A, Lopez-Sendon J, Hobbs FD, Grobbee DE, Boccanelli A, Cline C, Macarie C, Dietz R, Ruzyllo W. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J. 2005;26:2413–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Simon M, Boutouyrie P, Narayanan K, Gaye B, Tafflet M, Thomas F, Guibout C, Périer MC, Pannier B, Jouven X, Empana JP. Sex disparities in ideal cardiovascular health. Heart. 2017;103:1595–601.CrossRefPubMedGoogle Scholar
  35. 35.
    Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R, Working Group on Coronary Pathophysiology and Microcirculation. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res. 2011;90:9–17.CrossRefPubMedGoogle Scholar
  36. 36.
    Vitale C, Fini M, Spoletini I, Lainscak M, Seferovic P, Rosano GM. Under-representation of elderly and women in clinical trials. Int J Cardiol. 2017;232:216–21.CrossRefPubMedGoogle Scholar
  37. 37.
    Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, Burns R, Rayner M, Townsend N. European cardiovascular disease statistics 2017. Brussels: European Heart Network; 2017.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular SciencesUniversity of LeuvenLeuvenBelgium

Personalised recommendations